Dutasteride Capsule, Liquid Filled
Product Images NDC 50090-7852

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dutasteride (NDC 50090-7852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line graph comparing the mean change from baseline in AUA-SI over 24 months of treatment between Dutasteride and placebo groups. The x-axis represents months of treatment from 0 to 24, and the y-axis shows mean change from baseline in AUA-SI. Dutasteride shows a greater reduction in AUA-SI scores over time compared to placebo. Sample sizes for each group are reported at intervals on the graph.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A line graph comparing the cumulative percent of patients with events over 24 months of treatment in the Dutasteride group versus the placebo group. The x-axis represents months of treatment (0 to 24) and the y-axis shows the percent of patients (0 to 6%). The graph includes data tables with cumulative event counts and numbers at risk for both groups at selected time points.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph comparing the cumulative percentage of patients over 24 months of treatment between a placebo group and a dutasteride group. The X-axis shows months of treatment, and the Y-axis shows the percent of patients. The graph includes data on cumulative number of events and numbers at risk for both groups at specified time points.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A bar graph comparing mean percent change from baseline over months of treatment for Dutasteride and placebo groups. The x-axis indicates treatment duration in months (0, 1, 3, 6, 12, 24), and the y-axis shows mean percent change from baseline ranging from 0 to -30. Data include sample sizes for each group at each time point, with Dutasteride showing consistently greater reductions compared to placebo.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A line graph comparing mean change from baseline (mL/sec) over months of treatment between Dutasteride and placebo groups. The x-axis shows treatment duration from 0 to 24 months, and the y-axis shows mean change from baseline, ranging from 0 to 2 mL/sec. Dutasteride shows a higher mean increase over time compared to placebo, with sample sizes noted for each group at multiple time points.*
FDA Label Image

Figure-6 (Figure 6)

Figure-6 (Figure 6)
A line graph depicting mean change from baseline in IPSS over 48 months of treatment for three groups: Dutasteride plus tamsulosin, Dutasteride 0.5 mg, and Tamsulosin 0.4 mg. The x-axis represents months of treatment, while the y-axis represents mean change, showing the efficacy trends of each treatment group. Sample sizes (n) for each group are also noted.*
FDA Label Image

Figure-7 (Figure 7)

Figure-7 (Figure 7)
A line graph showing the mean change from baseline in mL/sec over 24 months of treatment for Dutasteride + tamsulosin, Dutasteride 0.5 mg, and Tamsulosin 0.4 mg. The x-axis represents months of treatment (0, 6, 12, 18, 24), and the y-axis represents mean change from baseline in mL/sec (0 to 3.0). Sample sizes for each treatment group at different months are noted below the graph.*
FDA Label Image

Structural-formula (Image 01)

Structural-formula (Image 01)
Chemical structure of dutasteride, showing its molecular bonds and functional groups typical of the compound.*
FDA Label Image

Label Image (Lbl500907852)

Label Image (Lbl500907852)
Label for Dutasteride 0.5 mg liquid-filled capsules by A-S Medication Solutions, Libertyville, IL. The label indicates each capsule contains 0.5 mg of Dutasteride, with storage instructions to keep at 77 degrees Fahrenheit. The package contains 30 capsules and includes NDC 50090-7852.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.